Dreyfus Andrew 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed May 31, 2019
Insider Transaction Report
Form 4
Dreyfus Andrew
Director
Transactions
- Award
Class A Common Stock
2019-05-29+22,706→ 80,813 total
Footnotes (1)
- [F1]The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.